Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

Xunlei Kang, Jaehyup Kim, Mi Deng Ph.D., Samuel John, Heyu Chen, Guojin Wu, Hiep Phan, Chengcheng Zhang

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1-5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit protein tyrosine phosphatase nonreceptor type 6 (PTPN6 or SHP-1), protein tyrosine phosphatase non-receptor type 11 (PTPN11 or SHP-2), or Src homology 2 domain-containing inositol phosphatase (SHIP), leading to negative regulation of immune cell activation. Certain of these receptors also play regulatory roles in neuronal activity and osteoclast development. The activation of LILRBs on immune cells by their ligands may contribute to immune evasion by tumors. Recent studies found that several members of LILRB family are expressed by tumor cells, notably hematopoietic cancer cells, and may directly regulate cancer development and relapse as well as the activity of cancer stem cells. LILRBs thus have dual concordant roles in tumor biology - as immune checkpoint molecules and as tumor-sustaining factors. Importantly, the study of knockout mice indicated that LILRBs do not affect hematopoiesis and normal development. Therefore LILRBs may represent ideal targets for tumor treatment. This review aims to summarize current knowledge on expression patterns, ligands, signaling, and functions of LILRB family members in the context of cancer development.

Original languageEnglish (US)
Pages (from-to)25-40
Number of pages16
JournalCell Cycle
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Immunoglobulins
Leukocytes
Non-Receptor Type 6 Protein Tyrosine Phosphatase
Neoplasms
Proteins
Tumor Escape
Ligands
Neoplastic Stem Cells
Hematopoiesis
Osteoclasts
Knockout Mice
Tyrosine
Recurrence

Keywords

  • Cancer
  • CD85
  • HLA
  • ILT
  • Immunoglobulin-like transcript
  • Immunoreceptor tyrosine-based activation motif
  • Immunoreceptor tyrosine-based inhibitory motifs
  • ITAM
  • ITIM
  • Leukemia
  • Leukocyte immunoglobulinlike receptor
  • Leukocyte immunoglobulinlike receptor subfamily B
  • LILRB
  • LIR
  • MHC
  • Phosphatase
  • SHIP
  • SHP-1
  • SHP-2
  • Signal transduction

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Developmental Biology

Cite this

Inhibitory leukocyte immunoglobulin-like receptors : Immune checkpoint proteins and tumor sustaining factors. / Kang, Xunlei; Kim, Jaehyup; Deng Ph.D., Mi; John, Samuel; Chen, Heyu; Wu, Guojin; Phan, Hiep; Zhang, Chengcheng.

In: Cell Cycle, Vol. 15, No. 1, 01.01.2016, p. 25-40.

Research output: Contribution to journalArticle

Kang, Xunlei ; Kim, Jaehyup ; Deng Ph.D., Mi ; John, Samuel ; Chen, Heyu ; Wu, Guojin ; Phan, Hiep ; Zhang, Chengcheng. / Inhibitory leukocyte immunoglobulin-like receptors : Immune checkpoint proteins and tumor sustaining factors. In: Cell Cycle. 2016 ; Vol. 15, No. 1. pp. 25-40.
@article{1939e7e78b8545de89c7c0f1e37755c2,
title = "Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors",
abstract = "Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1-5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit protein tyrosine phosphatase nonreceptor type 6 (PTPN6 or SHP-1), protein tyrosine phosphatase non-receptor type 11 (PTPN11 or SHP-2), or Src homology 2 domain-containing inositol phosphatase (SHIP), leading to negative regulation of immune cell activation. Certain of these receptors also play regulatory roles in neuronal activity and osteoclast development. The activation of LILRBs on immune cells by their ligands may contribute to immune evasion by tumors. Recent studies found that several members of LILRB family are expressed by tumor cells, notably hematopoietic cancer cells, and may directly regulate cancer development and relapse as well as the activity of cancer stem cells. LILRBs thus have dual concordant roles in tumor biology - as immune checkpoint molecules and as tumor-sustaining factors. Importantly, the study of knockout mice indicated that LILRBs do not affect hematopoiesis and normal development. Therefore LILRBs may represent ideal targets for tumor treatment. This review aims to summarize current knowledge on expression patterns, ligands, signaling, and functions of LILRB family members in the context of cancer development.",
keywords = "Cancer, CD85, HLA, ILT, Immunoglobulin-like transcript, Immunoreceptor tyrosine-based activation motif, Immunoreceptor tyrosine-based inhibitory motifs, ITAM, ITIM, Leukemia, Leukocyte immunoglobulinlike receptor, Leukocyte immunoglobulinlike receptor subfamily B, LILRB, LIR, MHC, Phosphatase, SHIP, SHP-1, SHP-2, Signal transduction",
author = "Xunlei Kang and Jaehyup Kim and {Deng Ph.D.}, Mi and Samuel John and Heyu Chen and Guojin Wu and Hiep Phan and Chengcheng Zhang",
year = "2016",
month = "1",
day = "1",
doi = "10.1080/15384101.2015.1121324",
language = "English (US)",
volume = "15",
pages = "25--40",
journal = "Cell Cycle",
issn = "1538-4101",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Inhibitory leukocyte immunoglobulin-like receptors

T2 - Immune checkpoint proteins and tumor sustaining factors

AU - Kang, Xunlei

AU - Kim, Jaehyup

AU - Deng Ph.D., Mi

AU - John, Samuel

AU - Chen, Heyu

AU - Wu, Guojin

AU - Phan, Hiep

AU - Zhang, Chengcheng

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1-5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit protein tyrosine phosphatase nonreceptor type 6 (PTPN6 or SHP-1), protein tyrosine phosphatase non-receptor type 11 (PTPN11 or SHP-2), or Src homology 2 domain-containing inositol phosphatase (SHIP), leading to negative regulation of immune cell activation. Certain of these receptors also play regulatory roles in neuronal activity and osteoclast development. The activation of LILRBs on immune cells by their ligands may contribute to immune evasion by tumors. Recent studies found that several members of LILRB family are expressed by tumor cells, notably hematopoietic cancer cells, and may directly regulate cancer development and relapse as well as the activity of cancer stem cells. LILRBs thus have dual concordant roles in tumor biology - as immune checkpoint molecules and as tumor-sustaining factors. Importantly, the study of knockout mice indicated that LILRBs do not affect hematopoiesis and normal development. Therefore LILRBs may represent ideal targets for tumor treatment. This review aims to summarize current knowledge on expression patterns, ligands, signaling, and functions of LILRB family members in the context of cancer development.

AB - Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1-5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit protein tyrosine phosphatase nonreceptor type 6 (PTPN6 or SHP-1), protein tyrosine phosphatase non-receptor type 11 (PTPN11 or SHP-2), or Src homology 2 domain-containing inositol phosphatase (SHIP), leading to negative regulation of immune cell activation. Certain of these receptors also play regulatory roles in neuronal activity and osteoclast development. The activation of LILRBs on immune cells by their ligands may contribute to immune evasion by tumors. Recent studies found that several members of LILRB family are expressed by tumor cells, notably hematopoietic cancer cells, and may directly regulate cancer development and relapse as well as the activity of cancer stem cells. LILRBs thus have dual concordant roles in tumor biology - as immune checkpoint molecules and as tumor-sustaining factors. Importantly, the study of knockout mice indicated that LILRBs do not affect hematopoiesis and normal development. Therefore LILRBs may represent ideal targets for tumor treatment. This review aims to summarize current knowledge on expression patterns, ligands, signaling, and functions of LILRB family members in the context of cancer development.

KW - Cancer

KW - CD85

KW - HLA

KW - ILT

KW - Immunoglobulin-like transcript

KW - Immunoreceptor tyrosine-based activation motif

KW - Immunoreceptor tyrosine-based inhibitory motifs

KW - ITAM

KW - ITIM

KW - Leukemia

KW - Leukocyte immunoglobulinlike receptor

KW - Leukocyte immunoglobulinlike receptor subfamily B

KW - LILRB

KW - LIR

KW - MHC

KW - Phosphatase

KW - SHIP

KW - SHP-1

KW - SHP-2

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84964262315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964262315&partnerID=8YFLogxK

U2 - 10.1080/15384101.2015.1121324

DO - 10.1080/15384101.2015.1121324

M3 - Article

C2 - 26636629

AN - SCOPUS:84964262315

VL - 15

SP - 25

EP - 40

JO - Cell Cycle

JF - Cell Cycle

SN - 1538-4101

IS - 1

ER -